Announcement
Joan Carles(Vall d'Hebron Hospital Universitari), Katsuhiko Hasumi(The Cancer Institute Hospital), Masaru Sakamoto(Jikei University School of Medicine), Yoshihiko Maehara(Kyushu University), Mario Sessarego, Kenji Umayahara, Eriko Tokunaga(National Hospital Organization Kyushu Cancer Center), Eugeni Saigí, Gerardo Rosati(Ospedale San Carlo), Tibor Görögh, R. Ibeas(Hospital Municipal de Badalona), K. Villadiego, Hiroko Sakamoto(Apple (Israel)), Asita Hoffmann-Fazel, Hiroshi Iwabuchi, J. D. Maass, Jens E. Meyer, Miquel Nogué(Hospital General de Granollers), H. Rudert, Peter Hohenberger(University of Mannheim), Eiji Oki(Kyushu University Hospital), Peter Reichardt(Helios Hospital Berlin-Buch), Jonathan Werner, S Maune, Shinji Ohno(Unknown), Franco Patrone, Naotake Tanaka, Nobuhiro Takeshima, Carlos J. Pérez, M. Doménech, Stefan Gottschlich, Peter Thuss‐Patience(Charité - Universitätsmedizin Berlin), Bernd Dörken(Charité - Universitätsmedizin Berlin), Paola Stura, D. Amoroso(Ospedale Versilia), Luigi Manzione, Kaoru Kitamura(Breast Cancer Care), Yutaka Suehiro, Akemi Kataoka, Shinya Oda, M. Dano Hoffmann, Inmaculada Guasch, Claus‐Henning Köhne(Klinikum Oldenburg), Kazuhiro Yamauchi, Albrecht Kretzschmar(Roche (Switzerland)), Antonio Rossi, T. Benter, Rosistella Chiacchio, Keizō Sugimachi(Kyushu University), Francesco Boccardo(University of Genoa)
Cited by 0
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2019|2.2k